These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 10702240

  • 1. Cathepsin G activates protease-activated receptor-4 in human platelets.
    Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR.
    J Biol Chem; 2000 Mar 10; 275(10):6819-23. PubMed ID: 10702240
    [Abstract] [Full Text] [Related]

  • 2. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A, Ansuini H, Celli N, De Blasi A, O'Brien PJ, Brass LF, Molino M.
    Thromb Haemost; 2001 Mar 10; 85(3):533-8. PubMed ID: 11307827
    [Abstract] [Full Text] [Related]

  • 3. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.
    Wu CC, Hwang TL, Liao CH, Kuo SC, Lee FY, Lee CY, Teng CM.
    Thromb Haemost; 2002 Jun 10; 87(6):1026-33. PubMed ID: 12083482
    [Abstract] [Full Text] [Related]

  • 4. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
    Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR.
    J Clin Invest; 1999 Mar 10; 103(6):879-87. PubMed ID: 10079109
    [Abstract] [Full Text] [Related]

  • 5. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
    Ramachandran R, Sadofsky LR, Xiao Y, Botham A, Cowen M, Morice AH, Compton SJ.
    Am J Physiol Lung Cell Mol Physiol; 2007 Mar 10; 292(3):L788-98. PubMed ID: 17142351
    [Abstract] [Full Text] [Related]

  • 6. Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand.
    Stoller ML, Basak I, Denorme F, Rowley JW, Alsobrooks J, Parsawar K, Nieman MT, Yost CC, Hamilton JR, Bray PF, Campbell RA.
    Blood Adv; 2022 Apr 12; 6(7):2303-2308. PubMed ID: 34883511
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
    French SL, Arthur JF, Lee H, Nesbitt WS, Andrews RK, Gardiner EE, Hamilton JR.
    J Thromb Haemost; 2016 Aug 12; 14(8):1642-54. PubMed ID: 26878340
    [Abstract] [Full Text] [Related]

  • 8. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
    Chen WF, Lee JJ, Chang CC, Lin KH, Wang SH, Sheu JR.
    Haematologica; 2013 May 12; 98(5):793-801. PubMed ID: 23065519
    [Abstract] [Full Text] [Related]

  • 9. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M.
    Am J Physiol; 1990 Jun 12; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [Abstract] [Full Text] [Related]

  • 10. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca2+ mobilization and ERK phosphorylation in healthy Japanese subjects.
    Morikawa Y, Kato H, Kashiwagi H, Nishiura N, Akuta K, Honda S, Kanakura Y, Tomiyama Y.
    Thromb Res; 2018 Feb 12; 162():44-52. PubMed ID: 29289806
    [Abstract] [Full Text] [Related]

  • 11. The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y12 inhibition.
    Whitley MJ, Henke DM, Ghazi A, Nieman M, Stoller M, Simon LM, Chen E, Vesci J, Holinstat M, McKenzie SE, Shaw CA, Edelstein LC, Bray PF.
    J Thromb Haemost; 2018 Dec 12; 16(12):2501-2514. PubMed ID: 30347494
    [Abstract] [Full Text] [Related]

  • 12. Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions.
    Rigg RA, Healy LD, Chu TT, Ngo ATP, Mitrugno A, Zilberman-Rudenko J, Aslan JE, Hinds MT, Vecchiarelli LD, Morgan TK, Gruber A, Temple KJ, Lindsley CW, Duvernay MT, Hamm HE, McCarty OJT.
    Platelets; 2019 Dec 12; 30(1):126-135. PubMed ID: 30560697
    [Abstract] [Full Text] [Related]

  • 13. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML, Hamm HE.
    J Pharmacol Exp Ther; 2007 Aug 12; 322(2):778-88. PubMed ID: 17525299
    [Abstract] [Full Text] [Related]

  • 14. Neutrophil cathepsin G modulates platelet P-selectin expression and inhibits P-selectin-mediated platelet-neutrophil adhesion.
    Ilton MK, Taylor ML, Misso NL, Thompson PJ, Hung J.
    Clin Sci (Lond); 1998 Apr 12; 94(4):437-45. PubMed ID: 9640350
    [Abstract] [Full Text] [Related]

  • 15. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G.
    Molino M, Blanchard N, Belmonte E, Tarver AP, Abrams C, Hoxie JA, Cerletti C, Brass LF.
    J Biol Chem; 1995 May 12; 270(19):11168-75. PubMed ID: 7744748
    [Abstract] [Full Text] [Related]

  • 16. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
    Judge HM, Jennings LK, Moliterno DJ, Hord E, Ecob R, Tricoci P, Rorick T, Kotha J, Storey RF.
    Platelets; 2015 May 12; 26(3):236-42. PubMed ID: 24750101
    [Abstract] [Full Text] [Related]

  • 17. Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking.
    Norman JE, Cunningham MR, Jones ML, Walker ME, Westbury SK, Sessions RB, Mundell SJ, Mumford AD.
    Arterioscler Thromb Vasc Biol; 2016 May 12; 36(5):952-60. PubMed ID: 26966273
    [Abstract] [Full Text] [Related]

  • 18. Cathepsin G and thrombin: evidence for two different platelet receptors.
    Selak MA.
    Biochem J; 1994 Jan 15; 297 ( Pt 2)(Pt 2):269-75. PubMed ID: 8297330
    [Abstract] [Full Text] [Related]

  • 19. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M, Vretenbrant-Oberg K, Nylander M, Désilets S, Lindström EG, Larsson A, Ramström I, Ramström S, Lindahl TL.
    J Biol Chem; 2008 Jul 04; 283(27):18493-504. PubMed ID: 18480058
    [Abstract] [Full Text] [Related]

  • 20. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin.
    Shapiro MJ, Weiss EJ, Faruqi TR, Coughlin SR.
    J Biol Chem; 2000 Aug 18; 275(33):25216-21. PubMed ID: 10837487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.